131 related articles for article (PubMed ID: 6797270)
1. [Adrianycin as intracavitary coadjuvant treatment of superficial bladder tumors. Our initial experiences].
Martínez Lasierra M; Caro Cebrián C; Sanz Vélez JI; Roncalés A; Rioja Sanz C
Actas Urol Esp; 1981; 5(4):219-22. PubMed ID: 6797270
[No Abstract] [Full Text] [Related]
2. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
[No Abstract] [Full Text] [Related]
3. Intravesical chemotherapy in the management of superficial bladder tumors.
Schulman CC
Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356
[No Abstract] [Full Text] [Related]
4. Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors.
Llopis B; Gallego J; Mompó JA; Boronat F; Jiménez JF
Eur Urol; 1985; 11(2):73-8. PubMed ID: 3924624
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of thiotepa and adriamycin as preventive intravesical treatment in non-infiltrating bladder tumors].
Lancina Martín JA; Mateo Cambón L; Casas Muiño RA; González Martín M
Actas Urol Esp; 1983; 7(4):269-74. PubMed ID: 6414263
[No Abstract] [Full Text] [Related]
6. [Cytostatic prophylactic treatment of superficial bladder tumours].
Lunglmayr G
Urologe A; 1972 Mar; 11(2):94-7. PubMed ID: 4623214
[No Abstract] [Full Text] [Related]
7. [Prevention of the recurrence of bladder tumors with local adriamycin therapy].
Somogyi L; Török A; Bors G; Frang D
Orv Hetil; 1984 Oct; 125(41):2503-6. PubMed ID: 6493764
[No Abstract] [Full Text] [Related]
8. [Intravesical chemical prevention of recurrence of superficial urothelial bladder cancer. Progress report of the Urology Clinic of Mainz University 1975-1981].
Jacobi GH; Engelmann U; Frohneberg D; Thüroff JW
Helv Chir Acta; 1982 Aug; 49(3-4):345-8. PubMed ID: 6813292
[No Abstract] [Full Text] [Related]
9. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M; McGarry R; Kupelnick B
Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
[TBL] [Abstract][Full Text] [Related]
10. [Progress in the internist treatment of bladder tumors].
Baumgartner G
Wien Med Wochenschr; 1982 Jul; 132(13-14):305-12. PubMed ID: 6814073
[TBL] [Abstract][Full Text] [Related]
11. The value of thiotepa in the treatment of superficial bladder tumors.
Akdaş A; Kirkali Z; Sengör F; Ilker Y; Taşar C
Turk J Pediatr; 1984; 26(1-4):243-50. PubMed ID: 6443167
[No Abstract] [Full Text] [Related]
12. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
Corrado F; Lalanne G; Pizza GC
Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
[No Abstract] [Full Text] [Related]
13. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
Llopis B; Sánchez A; Boronat F; Gallego J; Moreno B; Alonso M; Martínez R; Vera CD; Jiménez JF
Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
[No Abstract] [Full Text] [Related]
14. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
[TBL] [Abstract][Full Text] [Related]
15. Use of intravesical thiotepa in superficial bladder tumours.
Kulkarni JN; Kamat MR; Juvekar RL
Indian J Cancer; 1981 Sep; 18(3):222-4. PubMed ID: 6796504
[No Abstract] [Full Text] [Related]
16. [The topical use of doxorubicin in the prevention of recurrence of superficial tumors of the bladder after transurethral resection. Preliminary note].
Ghiron P; Borella T
Minerva Urol; 1982; 34(1):45-7. PubMed ID: 7087940
[No Abstract] [Full Text] [Related]
17. [Chemoprophylaxis of superficial bladder tumors. Results of the EORTC study].
Bouffioux C; Denis L; Debruyne F; Kurth KH; Schulman C
Acta Urol Belg; 1986; 54(2):175-87. PubMed ID: 3728219
[No Abstract] [Full Text] [Related]
18. Chemotherapy in superficial neoplasms of the bladder.
Zingg E; Sulmoni A
S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
[No Abstract] [Full Text] [Related]
19. Chemotherapy of bladder cancer: a review.
Smith PH
Cancer Treat Rep; 1981; 65 Suppl 1():165-73. PubMed ID: 6799197
[TBL] [Abstract][Full Text] [Related]
20. [Characteristic and effective usage of adriamycin].
Horiuchi K; Akimoto M
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
